Skip to main content
Fig. 2 | BMC Neurology

Fig. 2

From: Maximum resection and immunotherapy improve glioblastoma patient survival: a retrospective single-institution prognostic analysis

Fig. 2

The overall survival (OS) curve for the entire 277 GBM cohort (A) and this curve divided by EOR consisting of gross total removal (GTR), subtotal removal (STR), partial removal (PR) and biopsy (B); type of radiotherapies (RT), including proton therapy, conventional RT, hypofractionated RT (Hypofraction), whole brain RT (WBRT), and no RT (non) (C); and type of combination therapy including temozolomide (TMZ) + immunotherapy (IMT), TMZ, Bevacizumab (BEV) with or without TMZ, and others (D)

Back to article page

BMC Neurology

ISSN: 1471-2377

Contact us